Trust Board

Kathy joined the Trust as Chair in 2019 and brings over 40 years of public sector experience at national, local and regional levels.

From 2006-11, Kathy was chief executive of Wirral Primary Care Trust (PCT). She then spent two years as chief executive of Cheshire, Warrington and Wirral PCT Cluster from 2011-13.

In addition to having an in-depth understanding of the NHS, Kathy has a significant amount of leadership and board experience, having held non-executive and chairing roles in the NHS, housing and the third sector.

Joan has been Chief Executive of The Clatterbridge Cancer Centre since late March 2025. She was previously our Chief Operating Officer and Deputy Chief Executive.

Joan originally joined The Clatterbridge Cancer Centre in 2014 as General Manager of Chemotherapy, before becoming a member of the executive team as Interim Director of Operations in 2019. In 2022, she was appointed Chief Operating Officer and took on the additional post of Deputy Chief Executive in February 2024.

A cancer nurse by background, Joan worked at the Royal Liverpool University Hospital in various roles, including Lead Nurse for Breast Services (1997-2010), Associate Directorate Manager (2010-11) and Directorate Manager for Surgical Services (2011-14).

Tori was appointed Chief Operating Officer at the end of March 2025. She was previously our Director of Pharmacy and had also held the additional role of Deputy Chief Operating Officer since April 2024. 

Tori has extensive leadership experience across the Cheshire and Merseyside healthcare system. After qualifying as a pharmacist and completing her pre-reg training, Tori spent 18 years at Wirral University Teaching Hospital in roles including aseptics, haematology, women’s health, medicines management and medicines safety as her career progressed into management. She was Deputy Chief Pharmacist at Warrington and Halton Hospitals until joining The Clatterbridge Cancer Centre in February 2022.  

As Director of Pharmacy at The Clatterbridge Cancer Centre, Tori oversaw significant transformation of pharmacy services including increasing aseptic production, the launch of a full pharmacy logistics service and the introduction of new technology including Omnicells and VHP isolators. 

Dr Khanduri was appointed Medical Director at The Clatterbridge Cancer Centre in 2017. In addition to being Medical Director, Sheena continues to practise as a consultant clinical oncologist, specialising in breast cancer.

Originally from Birmingham, Sheena studied medicine at the University of Cambridge and trained in clinical oncology in the West Midland and Yorkshire Deaneries.

In 2007 she was appointed as a consultant at Shrewsbury and Telford Hospitals in Shropshire, where she was successively radiotherapy lead and departmental lead before becoming lead clinician for cancer services in 2016. She also served on the Heads of Service Committee for the Royal College of Radiologists.

Sheena has a postgraduate qualification in strategic leadership from the University of Warwick and completed the Strategic Clinical Leaders Programme with The King’s Fund in 2019.

Dr Khanduri is the Trust's Responsible Officer, Caldicott Guardian and Executive Lead for Research.

Julie joined The Clatterbridge Cancer Centre as Chief Nurse in 2021. She joined us from The Christie in Manchester, where she was Director of Nursing and Director of Infection Prevention and Control.

Julie qualified as a nurse in 1993 after training in Salford and at the Bolton School of Nursing and Midwifery, spending the first years of her career as a staff nurse in gastroenterology, intensive care, adult medicine and general surgery.

After working as a clinical tutor for a number of years, Julie joined The Christie in 2005 as a specialist nurse in blood transfusion and moved into more senior roles there as a nursing manager and then director. 

Julie has a strong interest in nurse education and professional development, and in transformation and continually improving quality of care. She has a longstanding commitment to improving the quality of care and experience of people with cancer.

Jane has been Director of Workforce and Organisational Development at The Clatterbridge Cancer Centre since the end of March 2025. She has also been Chief People Officer at Liverpool Heart and Chest Hospital since November 2023. 

Jane is a highly-experienced executive director and HR professional who has worked in the NHS for more than 30 years across primary care, mental health, community services and acute hospitals. Before joining Liverpool Heart and Chest Hospital, Jane was Director of Staff Engagement and Inclusion at Mersey and West Lancashire Teaching Hospitals. She was previously Director of HR and Organisational Development at Southport and Ormskirk Hospital. 

Jane is a Fellow of the Chartered Institute of Personnel and Development and has a Masters Degree in Strategic HR.

Jo has been Acting Director of Finance since 1st July 2025 and was previously our Deputy Director of Finance.

Jo trained with the Audit Commission and qualified as an accountant in 1999. She has experience across the public sector including the NHS, education, local authority, and police, fire and probation. Jo joined the NHS in 2005 and set up Mersey Internal Audit Agency's (MIAA) Manchester office. 

In 2008, she moved to Salford Primary Care Trust as a project accountant managing change programmes including the opening of five new health centres. She helped to set up NHS Property Services' Manchester office in 2012 before moving to Health Education England in 2015 as National Head of Financial Services.  

She joined The Clatterbridge Cancer Centre in April 2020 as Deputy Director of Finance. Since February 2021, she has also been a director of Clatterbridge Pharmacy Ltd (trading as PharmaC), our wholly-owned community pharmacy company. Jo's most recent achievements including establishing the PharmaC logistics service and negotiating the contract for PharmaC ro take over from Lloyds Pharmacy at Liverpool University Hospitals. 

Sarah joined the Trust as Chief Information Officer in 2017 and the Board as a non-voting member in 2019. 

Sarah has a degree in public management and a postgraduate diploma in health informatics. She achieved an Executive Healthcare Leadership award through the Nye Bevan Programme in 2019. 

Sarah has over 24 years’ experience working in digital and informatics and was previously Deputy Director of Informatics at Mersey Care NHS Foundation Trust.

Mark joined the Board in 2018 and brings with him significant experience as both an executive and non-executive director across the NHS, private and public sectors.

He has been Vice Chair of the Trust Board since 2021.

Geoff initially joined the Board as an associate non-executive director in 2018 and has been a full non-executive director since 2019. He has been the Senior Independent Director since January 2021.

Geoff has over 30 years’ experience in senior financial roles within the public and private sectors, including more than 20 years at board level. He has significant experience in corporate services, having managed finance, IT, human resources and facilities services. 

Geoff is Chair of our pharmacy subsidiary, PharmaC, and non-executive lead for Freedom to Speak Up at the Trust.

Elkan joined the Board in 2019. He qualified as a solicitor in 1983, working in Hong Kong and latterly in the United Kingdom, specialising in child care law and prisoners’ rights.

Elkan has significant board-level experience in the private sector and is a trustee of the Bloom Appeal, a local charity founded to help patients with blood cancers.

Terry brings a wealth of clinical experience and research expertise to the Board and is currently the Professor of Head and Neck Surgery at the University of Liverpool and Director of the Liverpool Head and Neck Centre. 

In addition to his clinical role as a head and neck cancer surgeon, Terry has led the development and delivery of many clinical trials and is currently Director of Research and Innovation at Liverpool University Hospitals and Director of Research for the Cheshire and Merseyside Integrated Care System.

Anna joined the Board in 2021. She was Lord Mayor of Liverpool from 2019 to 2021 and has an extensive and wide-ranging background in public service, with a particular focus on equality, business and community development initiatives.

Raised in Toxteth, Anna has represented the Princes Park ward of Liverpool as a councillor since 2006 and was the council’s Chair of Culture Tourism and Sport from 2010-13. She was the council’s first elected member to address the United Nations in Geneva on religious, cultural and linguistic differences.

Anna studied sociology, psychology and law and undertook a masters in business and regeneration in 2007 at the University of Liverpool.

Anna won the HSBC Ethnicity Award for a Political Figure in 2019 and the House of Lords Baton Award for most influential black female politician in the same year. She made history both by becoming Liverpool’s first black lord mayor and the first lord mayor in the city to be reappointed to the role – serving two terms.

Asutosh joined the Board in 2021. He began his career in pharmaceutical research and has an impressive track record as a strategic advisor, and in leadership and governance. 
Asutosh studying chemistry at the University of Exeter, he went on to gain a masters and doctorate in computational chemistry and rational drug design. In June 2009, he was awarded chartered scientist status by the UK Science Council.

After working as a research fellow, Asutosh moved into consultancy, where he advised global companies on strategy, transformation and supply chain. In 2003, he founded AdSidera, a leadership coaching and management consulting firm. He has been a member of organising committees for the Cura Foundation 2016, and 2018 Vatican Conferences on Regenerative Medicine.